News for Bioqual, Inc. (BIOQ)

Dr. Mark G. Lewis to retire as President and CEO of BIOQUAL (BIOQ) effective May 31, 2025. Dr. Hanne Andersen Elyard appointed as new President while co

Michael P. O'Flaherty to retire from BIOQUAL's Board effective May 1, 2025. O'Flaherty served as a director since 2015, post his COO tenure until 2015.

Q3 2025 net income for BIOQUAL (BIOQ) surged to $936,030 from $275,026 in Q3 2024. Quarterly revenue fell 8.5% to $14.03 million compared to the same pe

Read Bioqual (OTCMKTS:BIOQ) Shares Down 6.7% at ETF Daily News

Read Sunshine Biopharma (NASDAQ:SBFM) & Bioqual (OTCMKTS:BIOQ) Critical Analysis at ETF Daily News

Read Bioqual (OTCMKTS:BIOQ) versus Absci (NASDAQ:ABSI) Financial Comparison at ETF Daily News

Read Bioqual (OTCMKTS:BIOQ) & Zymergen (NASDAQ:ZY) Critical Survey at ETF Daily News

Read Head-To-Head Analysis: Bioqual (OTCMKTS:BIOQ) & Zymergen (NASDAQ:ZY) at ETF Daily News

Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace

DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT ...

Read Head-To-Head Analysis: Bioqual (OTCMKTS:BIOQ) versus MaxCyte (NASDAQ:MXCT) at ETF Daily News

Read Bioqual (OTCMKTS:BIOQ) versus Science 37 (NASDAQ:SNCE) Financial Survey at ETF Daily News